Can Boostrix (Tdap vaccine) be administered to a 9-year-old child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Boostrix Administration in 9-Year-Old Children

No, Boostrix cannot be given to a 9-year-old child—it is not licensed for use below age 10 years. 1

Licensing and Age Restrictions

The FDA licensing for Boostrix is explicitly clear on age limitations:

  • Boostrix minimum age: 10 years 1
  • Adacel minimum age: 11 years 1
  • Neither Tdap vaccine is licensed for children younger than 10 years of age 1

The 2007 immunization schedules from Pediatrics consistently state that Boostrix has a minimum age of 10 years, while Adacel has a minimum age of 11 years 1. This licensing restriction was maintained until 2011, when FDA expanded Boostrix to include adults 65 years and older, but the lower age limit of 10 years remained unchanged 2.

Appropriate Vaccine for 9-Year-Olds

For a 9-year-old child requiring tetanus-diphtheria-pertussis vaccination:

  • Use Td vaccine (tetanus-diphtheria toxoids) for catch-up vaccination 1
  • DTaP is not appropriate as it is not licensed for children ≥7 years and carries higher rates of adverse reactions in this age group 1, 3
  • The child should then receive Tdap at age 11-12 years to provide pertussis protection 1, 3

Special Circumstance: Children in Their 10th Year

There is one narrow exception in the guidelines:

  • A child in their 10th year of life (meaning they have already turned 10 years old) could receive Boostrix as part of catch-up vaccination 1
  • This applies only to children who are 10 years old, not those who are 9 years old 1

Critical Pitfall to Avoid

Do not administer Boostrix off-label to children under age 10 years. The vaccine has not been studied for safety or efficacy in this age group, and using it would violate FDA licensing restrictions 1. Instead, use Td vaccine for catch-up doses in children aged 7-9 years, followed by Tdap at the recommended age of 11-12 years 1, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tetanus, Diphtheria, and Pertussis Vaccination Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.